JPH0827101A - Crystallization of l-cystine and new crystals - Google Patents

Crystallization of l-cystine and new crystals

Info

Publication number
JPH0827101A
JPH0827101A JP15750494A JP15750494A JPH0827101A JP H0827101 A JPH0827101 A JP H0827101A JP 15750494 A JP15750494 A JP 15750494A JP 15750494 A JP15750494 A JP 15750494A JP H0827101 A JPH0827101 A JP H0827101A
Authority
JP
Japan
Prior art keywords
cystine
crystals
crystal
added
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP15750494A
Other languages
Japanese (ja)
Other versions
JP3541440B2 (en
Inventor
Satoru Kumon
哲 公文
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Priority to JP15750494A priority Critical patent/JP3541440B2/en
Publication of JPH0827101A publication Critical patent/JPH0827101A/en
Application granted granted Critical
Publication of JP3541440B2 publication Critical patent/JP3541440B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

PURPOSE:To stably obtain columnar crystals of L-cystine without particularly severe control of crystallization conditions by effecting the neutralization crystallization of L-cystine in the presence of a trace amount of a transition metal and metaphosphoric acid. CONSTITUTION:In the presence of a trace amount of a transition metal and a metaphosphoric acid, particularly hexametaphosphoric acid, Lcystine is subjected to neutralization crystallization. Thus, columnar crystals can be readily obtained, even in the cases that the concentration of L-cystine is high, or the crystallization temperature is low, or hydrochloric acid is used for neutralization. Further, the cystine solution is concentrated in the presence of a transition metal ion and metaphosphoric acid to give the columnar crystals. When a metaphosphoric acid is added in the absence of a transition metal ion, a new crystal of L-cystine is obtained, giving a diffraction pattern having peaks at the diffraction angles (2theta) of about 15.0 deg., 16.8 deg., 21.5 deg., 23.7 deg., 24.2 deg. and 28.8 deg. by X-ray diffraction powder method using Cu-Kalpha beam.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、医薬品原料として有用
なL−シスチンの晶析方法に関するものであり、特にL
−シスチンの柱状晶を取得する方法を提供するものであ
る。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for crystallizing L-cystine which is useful as a raw material for pharmaceuticals, and particularly to L-cystine.
-Provides a method for obtaining columnar crystals of cystine.

【0002】[0002]

【従来の技術】一般にL−シスチンの晶析は、等電点に
おけるL−シスチンの溶解度が極めて低い事から、主に
中和晶析によって行われている。しかし、この方法によ
って通常析出するL−シスチンの結晶は板状であり、こ
の結晶はろ過等により固液分離する際の分離速度が遅
く、また、結晶に残留する付着母液の量が多い問題点が
あった。分離速度が遅いと分離に所要する時間が長くな
り、多大の設備が必要になり、また、付着母液が多くな
ると、結晶の純度が悪くなる事に加え、結晶を洗浄する
水量も多大になる。更に、結晶中の含水量が多くなるこ
とから結晶の乾燥に要する熱量が多大になり、しかも乾
燥時に結晶が固結しやすくなる。この結晶型が板状であ
ることによる欠点は上記の様な付着母液量が多い事のみ
によるのでは無く、得られた乾燥品が飛散しやすく、ま
たその比容が大きい事にもあった。
2. Description of the Related Art Generally, crystallization of L-cystine is mainly carried out by neutralization crystallization because the solubility of L-cystine at its isoelectric point is extremely low. However, the crystals of L-cystine that are usually precipitated by this method are plate-like, and the crystals have a slow separation speed during solid-liquid separation by filtration and the amount of adhered mother liquor remaining in the crystals is large. was there. If the separation speed is slow, the time required for the separation is long and a large amount of equipment is required. Further, if the attached mother liquor is large, the purity of the crystals is deteriorated and the amount of water for washing the crystals is large. Furthermore, since the water content in the crystals is large, the amount of heat required for drying the crystals is large, and the crystals are likely to solidify during drying. The disadvantage of the crystal form being plate-like was not only due to the large amount of the adhering mother liquor as described above, but also because the obtained dried product was easily scattered and its specific volume was large.

【0003】L−シスチンの結晶としては、上記の板状
晶の他に柱状晶が知られている。(特開昭58−596
4)L−シスチンの柱状晶は特開昭58−59964に
見られるように、Cu−Kα線を用いて粉末X線回折法
で測定した場合に、約16.2゜及び約30.0゜の回
折角度(2θ)にピ−クを有する回折図形が得られる事
を特徴とする結晶であり、特開昭58−59964によ
れば、板状結晶の湿結晶の含水量が15〜30%である
のに対し、柱状晶は2〜6%であり、また製品の密比容
も板状晶の1.5〜3.5ml/gが、柱状晶では1.
3〜1.8ml/g程度に低下している。分離された結
晶の水分は、分離方法により変化し、ラボの様な低い遠
心力の遠心ろ過機で分離する場合、通常、板状結晶の水
分は15%以上、柱状結晶のそれは15%未満である。
As crystals of L-cystine, columnar crystals are known in addition to the above plate crystals. (JP-A-58-596
4) The columnar crystals of L-cystine are about 16.2 ° and about 30.0 ° when measured by powder X-ray diffractometry using Cu-Kα ray as seen in JP-A-58-59964. Is a crystal characterized in that a diffraction pattern having a peak at a diffraction angle (2θ) is obtained. According to JP-A-58-59964, the water content of wet crystals of plate-like crystals is 15 to 30%. On the other hand, the columnar crystal is 2 to 6%, and the dense specific volume of the product is 1.5 to 3.5 ml / g of the plate crystal, but 1.
It has dropped to about 3 to 1.8 ml / g. The water content of the separated crystals varies depending on the separation method, and when separated by a centrifugal filter with a low centrifugal force such as a lab, the water content of plate crystals is usually 15% or more and that of columnar crystals is less than 15%. is there.

【0004】柱状晶はこのようにその優位性の知られた
結晶型であるにもかかわらず、実際にはこれを晶析する
事が難しく、実用には使われ難い。なぜならば、特開昭
58−59964にも記述してあるごとく、この結晶を
得る条件の範囲が限られており、且つ、その範囲でも実
際には安定して柱状晶を得ることが難しいゆえである。
特開昭58−59964によれば、中和用酸の種類とし
ては塩酸より硫酸が良く、またL−シスチンの濃度は低
い方が良く、例えば10g/dlの溶液から柱状晶を得
るのは容易ではないとしている。また、晶析温度は50
℃とか80℃では柱状晶が比較的析出しやすいが、20
℃では柱状晶は得にくいとしている。一方、特開昭58
−59964は晶析の際にあらかじめ柱状晶をシ−ドす
る事は極めて有効であるとしている。しかしながら、こ
のような不安定な系で、シ−ド結晶を添加するにして
も、安定して柱状結晶を得続ける事は容易では無く、少
量の板状晶のシ−ド結晶への混入が柱状晶を得ることを
不可能にさせることは容易に予想出来る。事実、特開昭
58−59964の実施例ではシ−ド結晶を添加した系
でも、晶析は高濃度且つ高温で行われている。
Although the columnar crystal is a crystal type of which its superiority is known, it is difficult to crystallize it in practice and it is difficult to practically use it. This is because, as described in JP-A-58-59964, the range of conditions for obtaining this crystal is limited, and it is difficult to obtain columnar crystals stably even in that range. is there.
According to JP-A-58-59964, sulfuric acid is better than hydrochloric acid as the type of neutralizing acid, and the concentration of L-cystine is preferably lower. For example, it is easy to obtain columnar crystals from a solution of 10 g / dl. Not. The crystallization temperature is 50
At 80 ° C or 80 ° C, columnar crystals are likely to precipitate, but 20
It is said that columnar crystals are difficult to obtain at ℃. On the other hand, JP-A-58
-59964 says that it is extremely effective to seed the columnar crystals in advance during crystallization. However, in such an unstable system, even if a seed crystal is added, it is not easy to continuously obtain a columnar crystal, and a small amount of plate crystal is mixed into the seed crystal. Making columnar crystals impossible is easily predictable. In fact, in the example of JP-A-58-59964, crystallization is performed at a high concentration and at a high temperature even in the system in which the seed crystal is added.

【0005】[0005]

【発明が解決しようとする課題】L−シスチンの柱状晶
を安定的に取得する方法を開発する。
A method for stably obtaining columnar crystals of L-cystine is developed.

【0006】[0006]

【課題を解決するための手段】[Means for Solving the Problems]

【0007】本発明者らはL−シスチンの晶析における
上記のような問題点を解決すべく種々検討を行っていた
ところ、遷移金属イオンとメタリン酸の共存下でL−シ
スチンを中和晶析すると、上記のような問題点の無い柱
状晶が容易に得られることを見いだした。
The present inventors have conducted various studies to solve the above problems in crystallization of L-cystine, and found that L-cystine was neutralized in the presence of transition metal ions and metaphosphoric acid. It was found that columnar crystals free from the above problems can be easily obtained by analysis.

【0008】本発明者は、上記の問題点を解決すべく、
L−シスチンの単離精製工程で利点の多い柱状晶を容易
に得る方法を種々検討した結果、微量の遷移金属とメタ
リン酸、特にヘキサメタリン酸の共存下でL−シスチン
を晶析すると柱状晶が容易に得られることを見いだし
た。
The inventor of the present invention intends to solve the above problems.
As a result of various studies on a method of easily obtaining columnar crystals having many advantages in the isolation and purification step of L-cystine, when L-cystine was crystallized in the presence of a trace amount of transition metal and metaphosphoric acid, particularly hexametaphosphoric acid, columnar crystals were formed. I found it easy to get.

【0009】すなわち、遷移金属イオンとメタリン酸の
共存下でL−シスチンを中和晶析すると、L−シスチン
の濃度が高濃度であっても、晶析温度が低くても、また
中和用酸として塩酸を用いた場合でも柱状晶が容易に得
られた。また、柱状晶の結晶のシ−ドは全く必要としな
かった。また、遷移金属イオンとメタリン酸の共存下で
L−シスチンを濃縮晶析すると柱状晶が得られた。
That is, when L-cystine is neutralized and crystallized in the coexistence of a transition metal ion and metaphosphoric acid, the concentration of L-cystine is high, the crystallization temperature is low, and the neutralization is performed. Columnar crystals were easily obtained even when hydrochloric acid was used as the acid. Moreover, the seed of the columnar crystal was not required at all. Further, columnar crystals were obtained by concentrating crystallization of L-cystine in the coexistence of transition metal ions and metaphosphoric acid.

【0010】柱状結晶が得られたことは、結晶の粉末X
線回折によって確認された。湿結晶水分も板状晶が30
%前後であるのに対し、柱状晶は15%未満であった。
The fact that columnar crystals were obtained means that crystal powder X
Confirmed by line diffraction. Wet crystal Moisture content is 30 for plate crystals
%, While columnar crystals were less than 15%.

【0011】本発明に用いられるL−シスチンは、植物
性または動物性タンパク質の塩酸加水分解物より得られ
た粗製L−シスチンまたは精製L−シスチンであって
も、特定の基質から酵素法により製造された粗製L−シ
スチンまたは精製L−シスチンであってもよく、晶析可
能なL−シスチンであれば、その由来は問わない。
The L-cystine used in the present invention is a crude L-cystine obtained from a hydrochloric acid hydrolyzate of a plant or animal protein or a purified L-cystine, which is produced from a specific substrate by an enzymatic method. The crude L-cystine obtained may be purified L-cystine, or may be derived from any source as long as it can be crystallized.

【0012】遷移金属イオンとしては、アルミニウムイ
オン、亜鉛イオン、マンガンイオン、第1鉄イオンまた
は第2鉄イオンが使用できるが、特に第1鉄イオン、第
2鉄イオンが好ましい。また、メタリン酸としては、ペ
ンタメタリン酸、ヘキサメタリン酸またはヘプタメタリ
ン酸が使用できるが、特にヘキサメタリン酸が好まし
い。
As the transition metal ion, aluminum ion, zinc ion, manganese ion, ferrous ion or ferric ion can be used, and ferrous ion and ferric ion are particularly preferred. As metaphosphoric acid, pentametaphosphoric acid, hexametaphosphoric acid or heptametaphosphoric acid can be used, and hexametaphosphoric acid is particularly preferred.

【0013】遷移金属イオンとメタリン酸の共存下にお
ける晶析に於て、メタリン酸の濃度は、例えばヘキサメ
タリン酸の場合、1〜2mg/Lから有効であり、10
00mg/Lでも有効であった。遷移金属イオンはイオ
ンとして溶液中に溶解していることが必要であるが、そ
の必要最低濃度は添加するメタリン酸の濃度に関係し、
例えば、ヘキサメタリン酸の濃度が100mg/Lのと
きには、1〜9mg/Lで有効である。また、ヘキサメ
タリン酸の濃度が1000mg/Lのときには、10〜
90mg/Lで有効である。
In crystallization in the presence of transition metal ions and metaphosphoric acid, the concentration of metaphosphoric acid is effective from 1 to 2 mg / L in the case of hexametaphosphoric acid.
Even 00 mg / L was effective. The transition metal ion needs to be dissolved in the solution as an ion, but the required minimum concentration is related to the concentration of metaphosphoric acid added,
For example, when the concentration of hexametaphosphoric acid is 100 mg / L, 1-9 mg / L is effective. Further, when the concentration of hexametaphosphoric acid is 1000 mg / L, 10 to 10
Effective at 90 mg / L.

【0014】得られたL−シスチンの柱状晶は通常どう
り分離、水洗すれば添加されたメタリン酸は洗い流さ
れ、良好な品質の製品が得られる。しかしながら、この
場合でも、添加されるメタリン酸濃度の低い方が洗浄水
の量が少なくてすむのは当然である。
The columnar crystals of L-cystine thus obtained are usually separated and washed with water to wash away the added metaphosphoric acid, and a product of good quality is obtained. However, even in this case, it is natural that the lower the concentration of the added metaphosphoric acid, the smaller the amount of washing water.

【0015】上記の板状と柱状の二種類のL−シスチン
結晶は、理学的にはα晶(板状)とβ晶(柱状)として
知られており(永嶋伸也、日本結晶学会誌、35、38
1(1993))、その結晶構造の解析もされている。
また上記の特開昭58−59964に、両結晶の溶解度
が示されており、それによれば、β晶はα晶よりも若干
溶解度が高く、これは一般的にはα晶が安定的に存在し
得、特殊な環境下でのみβ晶が存在し得る事を意味す
る。上記、特開昭58−59964ではこの環境をL−
シスチン濃度、温度、酸の種類を限定することによって
達し得ているのであるが、実際に工業的にこのような狭
い範囲で操作することは現実的であるとは言い難い。本
発明は、添加物により、特に晶析条件を厳しく限定する
ことなくβ晶を得ることができる様にしたことに特徴が
あり、その工業的有用性は大きい。
The above-mentioned two types of L-cystine crystals, plate-shaped and column-shaped, are known as α crystals (plate-shaped) and β crystals (column-shaped) in theory (Shinya Nagashima, Journal of the Crystallographic Society of Japan, 35). , 38
1 (1993)), and its crystal structure has also been analyzed.
Further, the above-mentioned JP-A-58-59964 shows the solubility of both crystals. According to this, the solubility of β-crystal is slightly higher than that of α-crystal, which is generally stable in α-crystal. It means that β crystal can exist only under a special environment. In the above-mentioned Japanese Patent Laid-Open No. 58-59964, this environment is
This can be achieved by limiting the cystine concentration, temperature, and type of acid, but it is difficult to say that it is practical to industrially operate in such a narrow range. The present invention is characterized in that a β crystal can be obtained by an additive without particularly limiting the crystallization conditions, and its industrial utility is great.

【0016】本発明の作用原理については、更に理学的
検討を要すが、下記のような原理であると考えている。
メタリン酸は一般にキレ−ト剤として使用され、ボイラ
−清浄剤、印刷製版、ナメシなどの方面に用いられてい
る。本発明では遷移金属イオンはメタリン酸と錯体を形
成し、この錯体がL−シスチンのα晶に対し結晶成長阻
害効果を持ち、通常では準安定なβ晶を安定的に存在せ
しめていると考えている。
The working principle of the present invention requires further scientific study, but is believed to be as follows.
Metaphosphoric acid is generally used as a chelating agent, and is used for boiler detergents, printing plates, shavings and the like. In the present invention, it is considered that the transition metal ion forms a complex with metaphosphoric acid, and this complex has a crystal growth inhibitory effect on the α crystal of L-cystine, and normally causes a metastable β crystal to exist stably. ing.

【0017】一方、発明者らはL−シスチンの結晶化に
当り、遷移金属の存在しない状態でメタリン酸を添加す
ると、Cu−Kα線を用いた粉末X線回折法で、上記の
α晶、β晶とは異なる回折図形を持つ結晶が析出、成長
する事を見いだした。この結晶の回折角度(2θ)は、
α晶と共通するものが多いが、特徴的に約15.0度、
16.8度、21.5度、23.7度、24.2、及び
28.8度にピ−クを有する。このような回折角度を有
する結晶は従来知られておらず、新規結晶である。この
新規結晶の外観は針状であり、上記のα晶、β晶とは大
きく異なっていた。この結晶はα晶、β晶に比べ、分離
性が悪く、また結晶に付着する水分量も多いが、逆に乾
燥後の結晶間の空間が大きく、結晶を水、又は希酸等に
溶解するときに、結晶間に溶媒が早く入り込み、他の結
晶に比べ溶解する速度が速い性質を有していた。
On the other hand, when crystallizing L-cystine, the present inventors added metaphosphoric acid in the absence of a transition metal to the above-mentioned α crystal by powder X-ray diffraction method using Cu-Kα ray. We found that crystals with a diffraction pattern different from that of β crystals were deposited and grew. The diffraction angle (2θ) of this crystal is
Many are common with α crystals, but characteristically about 15.0 degrees,
It has peaks at 16.8 degrees, 21.5 degrees, 23.7 degrees, 24.2 degrees, and 28.8 degrees. A crystal having such a diffraction angle has not hitherto been known and is a novel crystal. The appearance of this new crystal was needle-like, and was significantly different from the above α crystal and β crystal. Compared with α crystal and β crystal, this crystal has poor separability and has a large amount of water adhering to the crystal, but on the contrary, the space between crystals after drying is large, and the crystal dissolves in water, dilute acid or the like. At times, the solvent entered between the crystals quickly, and had a property of dissolving at a higher rate than other crystals.

【0018】L−シスチンは通常、溶媒に溶解し、電解
還元し、L−システインに変換した後、医薬原料にする
か、乃至は、そのまま適当な溶媒に溶解し、パ−マ用の
処理液にする。いずれにしろ、その用途の大半は、結晶
のまま使うことはなく、一度何らかの溶媒に溶解した後
に使用する。この場合、L−シスチンの水に対する溶解
度が蛋白質構成アミノ酸の中ではL−チロシンに次いで
低い為、溶解に多大の時間の要する事が問題になる。発
明者が新たに見いだした針状の新規結晶は、この使用に
当たる溶解速度の問題を解決する物として期待される。
L-cystine is usually dissolved in a solvent, subjected to electrolytic reduction and converted to L-cysteine, and then used as a medicinal raw material or, as it is, dissolved in an appropriate solvent to prepare a treatment solution for a palmer. To In any case, most of the uses are not used as crystals, and are used after once dissolved in some solvent. In this case, the solubility of L-cystine in water is second lowest to that of L-tyrosine among protein-constituting amino acids, so that it takes a long time to dissolve, which is a problem. The novel needle-like crystals newly found by the inventor are expected to solve the problem of dissolution rate in this use.

【0019】更に、メタリン酸存在下では中和晶析時の
結晶の出始める(起晶)pHが高く、通常のα晶に比
べ、同一pHではより高濃度迄溶液状態を保ち得る。こ
の事は、人毛の加水分解物を中和し、まずチロシンを析
出除去させるに当り、より高いpH迄上げた状態でチロ
シンを分離できることを意味し、チロシンの除去率を上
げられることから、シスチンの精製に有利に働く。
Further, in the presence of metaphosphoric acid, the pH at which crystals start to emerge (neutralization) during neutralization crystallization is high, and the solution state can be maintained up to a higher concentration at the same pH as in the case of normal α crystal. This means that when neutralizing the hydrolyzate of human hair and first removing and depositing tyrosine, it is possible to separate tyrosine at a higher pH, and it is possible to increase the removal rate of tyrosine. It has an advantageous effect on the purification of cystine.

【0020】この新規結晶はメタリン酸、例えばヘキサ
メタリン酸単独の添加により得られ、その濃度は1〜1
0mg/Lから有効である。一方、発明者は限られた金
属、例えば、ニッケルまたはコバルトをメタリン酸に対
する当量比で2分の1から50分の1添加すると粒径の
大きい結晶の得られる事を見いだした。これらの金属は
イオンとして溶解している必要がある。メタリン酸のみ
存在する系で晶析すると、その濃度にも依るが、長軸側
の長さは0.1mm前後乃至はそれよりも小さいが、上
記の金属の共存下では0.1mmよりも大きく、1mm
に達するものもある。
The new crystals are obtained by adding metaphosphoric acid, for example hexametaphosphoric acid alone, the concentration of which is from 1 to 1.
Effective from 0 mg / L. On the other hand, the inventor has found that a crystal having a large grain size can be obtained by adding a limited metal, for example, nickel or cobalt in an equivalent ratio of 1/2 to 1/50 to metaphosphoric acid. These metals need to be dissolved as ions. When crystallized in a system in which only metaphosphoric acid is present, the length on the major axis side is about 0.1 mm or smaller than that depending on the concentration, but in the presence of the above metals, it is larger than 0.1 mm. 1 mm
Some reach.

【0021】一般的に、添加物は対照となる結晶の成長
面に付着し、母体の分子の結晶への吸着を阻害し、結晶
成長に影響を与えるので、好ましくないが、最近、結晶
の分離・乾燥工程を合理化する、又は、医薬品等の用途
で、結晶の溶解速度等を調節する目的で添加物により結
晶型(構造、外形)を変化させる研究が多く行われてい
る。本発明もその内の一つであり、巧みに結晶の構造、
外形を変化させることのできた例である。
In general, the additive adheres to the growth surface of the control crystal and inhibits the adsorption of the host molecule to the crystal, which affects the crystal growth. -Many studies have been conducted to change the crystal form (structure, outer shape) by additives for the purpose of rationalizing the drying process, or adjusting the dissolution rate of crystals in applications such as pharmaceuticals. The present invention is also one of them, and skillfully crystal structure,
This is an example in which the outer shape could be changed.

【0022】[0022]

【実施例】以下、実施例によって本発明を詳しく説明す
る。実施例で得られた結晶の粉末X線回折は、Phil
ips社製PW1700型粉末X線回折装置を用い、線
源としてCu−Kα線を使用して測定した。
EXAMPLES The present invention will be described in detail below with reference to examples. The powder X-ray diffraction of the crystals obtained in the examples is Phil.
The measurement was performed using a PW1700 powder X-ray diffractometer manufactured by ips and using Cu-Kα ray as a radiation source.

【0023】実施例1 3.5gのL−シスチンに4%HClを50ml添加
し、溶解後、塩化第二鉄六水和物9.7mgを添加溶解
後、更にヘキサメタリン酸ナトリウムを5.5mgを添
加し、溶解後35℃で攪拌しながら27%NaOHを1
5ml/hrで添加した。約32分後、pHが0.68
となった時点で結晶が出始めたのでNaOH添加を一旦
停止した。24分後にNaOH添加を再開し、pH2と
した時点で中和を終了した。得られた結晶は柱状晶であ
り、ろ過により分離した湿結晶の含水率は9%であっ
た。結晶の粉末X線回折によると結晶型はβ晶であっ
た。この結晶の粉末X線回折図を図1に示す。
Example 1 To 3.5 g of L-cystine, 50 ml of 4% HCl was added, and after dissolution, 9.7 mg of ferric chloride hexahydrate was added and dissolved, and further 5.5 mg of sodium hexametaphosphate was added. Add, dissolve and add 1% of 27% NaOH with stirring at 35 ° C.
Added at 5 ml / hr. After about 32 minutes, the pH is 0.68
At this point, crystals started to appear, so the addition of NaOH was stopped once. After 24 minutes, the addition of NaOH was restarted, and the neutralization was completed when the pH was adjusted to pH 2. The obtained crystals were columnar crystals, and the water content of the wet crystals separated by filtration was 9%. According to powder X-ray diffraction of the crystal, the crystal form was β crystal. The powder X-ray diffraction pattern of this crystal is shown in FIG.

【0024】実施例2 3.5gのL−シスチンに4%HClを50ml添加
し、溶解後、塩化第二鉄六水和物97mgを添加溶解
後、更にヘキサメタリン酸ナトリウムを55mgを添加
し、溶解後35℃で攪拌しながら27%NaOHを15
ml/hrで添加した。約20分後、pHが0.61と
なった時点で結晶が出始めたのでNaOH添加を一旦停
止した。27分後にNaOH添加を再開し、pH2とし
た時点で中和を終了した。得られた結晶は柱状晶であ
り、ろ過により分離した湿結晶の含水率は12%であっ
た。結晶の粉末X線回折によると結晶型は主としてβ晶
であった。
Example 2 To 3.5 g of L-cystine, 50 ml of 4% HCl was added, and after dissolution, 97 mg of ferric chloride hexahydrate was added and dissolved, and further 55 mg of sodium hexametaphosphate was added and dissolved. After that, add 15% of 27% NaOH while stirring at 35 ° C.
It was added at ml / hr. Approximately 20 minutes later, when the pH reached 0.61, crystals started to appear, so the addition of NaOH was stopped once. After 27 minutes, the addition of NaOH was restarted, and the neutralization was completed when the pH was adjusted to pH 2. The obtained crystals were columnar crystals, and the water content of the wet crystals separated by filtration was 12%. According to powder X-ray diffraction of the crystal, the crystal form was mainly β crystal.

【0025】実施例3 3.5gのL−シスチンに4%HClを50ml添加
し、溶解後、塩化第二鉄六水和物4.8mgを添加溶解
後、更にヘキサメタリン酸ナトリウムを5.5mgを添
加し、溶解後35℃で攪拌しながら27%NaOHを1
5ml/hrで添加した。約20分後、pHが0.61
となった時点で結晶が出始めたのでNaOH添加を一旦
停止した。47分後にNaOH添加を再開し、pH2と
した時点で中和を終了した。得られた結晶は柱状晶であ
り、ろ過により分離した湿結晶の含水率は3%であっ
た。結晶の粉末X線回折によると結晶型は主としてβ晶
であった。
Example 3 To 3.5 g of L-cystine, 50 ml of 4% HCl was added, and after dissolution, 4.8 mg of ferric chloride hexahydrate was added and dissolved, and further 5.5 mg of sodium hexametaphosphate was added. Add, dissolve and add 1% of 27% NaOH with stirring at 35 ° C.
Added at 5 ml / hr. After about 20 minutes, the pH is 0.61
At this point, crystals started to appear, so the addition of NaOH was stopped once. After 47 minutes, the addition of NaOH was restarted, and the neutralization was completed when the pH was adjusted to pH 2. The obtained crystals were columnar crystals, and the water content of the wet crystals separated by filtration was 3%. According to powder X-ray diffraction of the crystal, the crystal form was mainly β crystal.

【0026】実施例4 3.5gのL−シスチンにあらかじめ脱気処理した4%
HClを50ml添加し、溶解後、亜硫酸ナトリウムを
0.5g添加溶解し、溶解後塩化第一鉄・n水和物を1
1.7mg添加、溶解し、更にヘキサメタリン酸ナトリ
ウムを5.5mgを添加し、溶解後35℃で攪拌しなが
ら27%NaOHを15ml/hrで添加した。約14
分後、pHが0.61となった時点でNaOH添加を1
0分間停止した。その後、pHを0.68迄上昇させ
た。結晶が出始めたのでNaOH添加を一旦停止した。
47分後にNaOH添加を再開し、pH2とした時点で
中和を終了した。得られた結晶は柱状晶であり、ろ過に
より分離した湿結晶の含水率は10%であった。結晶の
粉末X線回折によると結晶型は主としてβ晶であった。
Example 4 3.5 g of L-cystine was previously degassed to 4%
50 ml of HCl was added, and after dissolution, 0.5 g of sodium sulfite was added and dissolved, and after dissolution, 1 part of ferrous chloride / n hydrate was dissolved.
1.7 mg was added and dissolved, 5.5 mg of sodium hexametaphosphate was further added, and 27% NaOH was added at 15 ml / hr while stirring at 35 ° C. after dissolution. About 14
After 1 minute, when the pH reached 0.61, add 1 NaOH.
It stopped for 0 minutes. Then the pH was raised to 0.68. Since crystals started to appear, the addition of NaOH was stopped once.
After 47 minutes, the addition of NaOH was restarted, and the neutralization was completed when the pH was adjusted to pH 2. The obtained crystals were columnar crystals, and the water content of the wet crystals separated by filtration was 10%. According to powder X-ray diffraction of the crystal, the crystal form was mainly β crystal.

【0027】実施例5 3.5gのL−シスチンに4%HClを50ml添加
し、溶解後、塩化アルミニウム6水和物を8.7mg添
加、溶解し、更にヘキサメタリン酸ナトリウムを5.5
mgを添加し、溶解後35℃で攪拌しながら27%Na
OHを15ml/hrで添加した。約21分後、pHが
0.61となった時点で結晶が出始めたのでNaOH添
加を停止した。33分後にNaOH添加を再開し、pH
2とした時点で中和を終了した。得られた結晶は主とし
て柱状晶であったが、極く少量の針状晶も含有してい
た。ろ過により分離した湿結晶の含水率は14%であっ
た。結晶の粉末X線回折によると結晶型は主としてβ晶
であった。
Example 5 To 3.5 g of L-cystine, 50 ml of 4% HCl was added, and after dissolution, 8.7 mg of aluminum chloride hexahydrate was added and dissolved, and sodium hexametaphosphate was added to 5.5.
mg was added, and after dissolution, 27% Na was added with stirring at 35 ° C.
OH was added at 15 ml / hr. Approximately 21 minutes later, when the pH reached 0.61, crystals began to appear, so the addition of NaOH was stopped. After 33 minutes, restart the NaOH addition and
The neutralization was completed at the time point of 2. The obtained crystals were mainly columnar crystals, but also contained a very small amount of needle-like crystals. The wet crystal separated by filtration had a water content of 14%. According to powder X-ray diffraction of the crystal, the crystal form was mainly β crystal.

【0028】実施例6 3.5gのL−シスチンに4%HClを50ml添加
し、溶解後、ヘキサメタリン酸ナトリウムを5.5mg
を添加し、溶解後35℃で攪拌しながら27%NaOH
を15ml/hrで添加した。約20分後、pHが0.
61となった時点でNaOH添加を6分間停止し、その
後、pHを0.68迄上昇させた。結晶が出始めたので
NaOH添加を一旦停止した。74分後にNaOH添加
を再開し、pH2とした時点で中和を終了した。得られ
た結晶は針状晶であり、ろ過により分離した湿結晶の含
水率は73%であった。この結晶を乾燥後、Cu−Kα
線を用いた粉末X線回折を測定した。その結果、この結
晶の回折角度(2θ)は、α晶と共通するものが多い
が、特徴的に約15.0度、16.8度、21.5度、
23.7度、24.2度、及び28.8度にピ−クを有
していた。この結晶の粉末X線回折図を図2に示す。
Example 6 To 3.5 g of L-cystine, 50 ml of 4% HCl was added, and after dissolution, 5.5 mg of sodium hexametaphosphate was added.
Was added, and after dissolution, 27% NaOH was added with stirring at 35 ° C.
Was added at 15 ml / hr. After about 20 minutes, the pH was 0.
At 61, NaOH addition was stopped for 6 minutes and then the pH was raised to 0.68. Since crystals started to appear, the addition of NaOH was stopped once. After 74 minutes, the addition of NaOH was restarted, and the neutralization was terminated when the pH was adjusted to pH 2. The obtained crystals were needle crystals, and the water content of the wet crystals separated by filtration was 73%. After drying this crystal, Cu-Kα
X-ray powder diffraction using X-ray was measured. As a result, the diffraction angle (2θ) of this crystal is often the same as that of α crystal, but characteristically about 15.0 degrees, 16.8 degrees, 21.5 degrees,
It had peaks at 23.7 degrees, 24.2 degrees, and 28.8 degrees. The powder X-ray diffraction pattern of this crystal is shown in FIG.

【0029】実施例7 3.5gのL−シスチンに4%HClを50ml添加
し、溶解後、2価の塩化ニッケル・6水和物の12.8
mgを添加、溶解後、更に、ヘキサメタリン酸ナトリウ
ムを5.5mgを添加し、溶解後35℃で攪拌しながら
27%NaOHを15ml/hrで添加した。約21分
後、pHが0.61となった時点でNaOH添加を5分
間停止し、その後、pHを0.65迄上昇させ、NaO
Hを一旦停止したが起晶しなかったので、更にpHを
0.68迄上昇させた。結晶が出始めたのでNaOH添
加を一旦停止した。76分後にNaOH添加を再開し、
pH2とした時点で中和を終了した。得られた結晶は粒
径の大きな針状晶であり、ろ過により分離した湿結晶の
含水率は76%であった。この結晶を乾燥後、Cu−K
α線を用いた粉末X線回折を測定した。その結果、実施
例6の結晶と同じ回折パタ−ンを有していた。
Example 7 To 3.5 g of L-cystine, 50 ml of 4% HCl was added, and after dissolution, 12.8 of divalent nickel chloride hexahydrate.
After adding and dissolving mg, 5.5 mg of sodium hexametaphosphate was further added, and after dissolving, 27% NaOH was added at 15 ml / hr while stirring at 35 ° C. After about 21 minutes, when the pH reached 0.61, the addition of NaOH was stopped for 5 minutes, and then the pH was raised to 0.65 and NaO was added.
Since H was once stopped but no crystallization occurred, the pH was further raised to 0.68. Since crystals started to appear, the addition of NaOH was stopped once. After 76 minutes, restart the NaOH addition,
The neutralization was completed when the pH was adjusted to pH 2. The obtained crystals were needle-shaped crystals with a large particle size, and the water content of the wet crystals separated by filtration was 76%. After drying this crystal, Cu-K
Powder X-ray diffraction using α ray was measured. As a result, it had the same diffraction pattern as the crystal of Example 6.

【0030】比較例1 3.5gのL−シスチンに4%HClを50ml添加
し、溶解後、35℃で攪拌しながら27%NaOHを1
5ml/hrで添加した。約19分後、pHが0.61
に達した時点で結晶が出始めたのでNaOH添加を一旦
停止した。26分後にNaOH添加を再開し、pH3と
した時点で中和終了した。得られた結晶は柱状晶、板状
晶の混合物であり、ろ過により分離した湿結晶の含水率
は36%であった。結晶の粉末X線回折によると結晶型
はα晶とβ晶の混合物であった。
Comparative Example 1 To 3.5 g of L-cystine was added 50 ml of 4% HCl, and after dissolution, 1% of 27% NaOH was added with stirring at 35 ° C.
Added at 5 ml / hr. After about 19 minutes, the pH is 0.61
At that point, crystals started to appear, so the addition of NaOH was stopped once. After 26 minutes, the addition of NaOH was restarted, and the neutralization was completed when the pH was adjusted to pH 3. The obtained crystals were a mixture of columnar crystals and plate crystals, and the water content of the wet crystals separated by filtration was 36%. According to powder X-ray diffraction of the crystal, the crystal form was a mixture of α crystal and β crystal.

【0031】比較例2 3.5gのL−シスチンに4%HClを50ml添加
し、溶解後、塩化第二鉄六水和物97mgを添加溶解
後、35℃で攪拌しながら27%NaOHを15ml/
hrで添加した。約19分後、pHが0.61となった
時点で結晶が出始めたのでNaOH添加を一旦停止し
た。25分後にNaOH添加を再開し、pH2とした時
点で中和を終了した。得られた結晶は板状晶と柱状晶の
混合物であり、ろ過により分離した湿結晶の含水率は2
8%であった。結晶の粉末X線回折によると結晶型はα
晶とβ晶の混合物であった。
Comparative Example 2 To 3.5 g of L-cystine, 50 ml of 4% HCl was added, and after dissolution, 97 mg of ferric chloride hexahydrate was added and dissolved. Then, 15 ml of 27% NaOH was added with stirring at 35 ° C. /
added at hr. Approximately 19 minutes later, when the pH reached 0.61, crystals started to appear, so the addition of NaOH was stopped once. After 25 minutes, the addition of NaOH was restarted, and the neutralization was completed when the pH was adjusted to 2. The obtained crystals were a mixture of plate-like crystals and columnar crystals, and the water content of the wet crystals separated by filtration was 2
It was 8%. According to powder X-ray diffraction of the crystal, the crystal form is α
It was a mixture of crystals and β crystals.

【0032】比較例3 3.5gのL−シスチンにあらかじめ脱気処理した4%
HClを50ml添加し、溶解後、亜硫酸ナトリウムを
0.5g添加し、溶解後35℃で攪拌しながら27%N
aOHを15ml/hrで添加した。約13分後、pH
が0.61となった時点でNaOH添加を停止した。結
晶が出始めたのでNaOH添加を一旦停止した。20分
後にNaOH添加を再開し、pH2とした時点で中和を
終了した。得られた結晶は板状晶と針状晶の混合物であ
り、ろ過により分離した湿結晶の含水率は56%であっ
た。結晶の粉末X線回折によると結晶型はほぼα晶であ
った。
Comparative Example 3 3.5 g of L-cystine was previously degassed to 4%
50 ml of HCl was added, after dissolution, 0.5 g of sodium sulfite was added, and after dissolution, 27% N was added while stirring at 35 ° C.
aOH was added at 15 ml / hr. After about 13 minutes, pH
When the value reached 0.61, the addition of NaOH was stopped. Since crystals started to appear, the addition of NaOH was stopped once. After 20 minutes, the addition of NaOH was restarted, and the neutralization was completed when the pH was adjusted to pH 2. The obtained crystals were a mixture of plate crystals and needle crystals, and the water content of the wet crystals separated by filtration was 56%. According to powder X-ray diffraction of the crystal, the crystal form was almost α crystal.

【0033】[0033]

【発明の効果】本発明により、特に晶析条件を厳しく限
定することなく、柱状晶を得ることができる様になり、
その工業的有用性は大きい。柱状晶は、晶析母液との分
離性が良好、含水量が少ないなど板状晶に比べ利点が多
い。また、本発明の新規なL−シスチンの針状結晶は、
水又は希酸等に溶解するときに、結晶間に溶媒が早く入
り込み、他の結晶に比べ溶解する速度が速い性質を有し
ており、L−シスチンの溶解速度の問題を解決する物と
して期待される。
According to the present invention, columnar crystals can be obtained without particularly restricting crystallization conditions.
Its industrial utility is great. The columnar crystals have many advantages over the plate-like crystals, such as good separation from the crystallization mother liquor and low water content. The novel needle crystal of L-cystine of the present invention is
When dissolved in water or dilute acid, etc., the solvent enters the crystals faster and has a higher dissolution rate than other crystals, which is expected as a solution to the problem of the dissolution rate of L-cystine. To be done.

【図面の簡単な説明】[Brief description of drawings]

【図1】実施例1で得られたL−シスチンの柱状晶の粉
末X線回折図である。
FIG. 1 is a powder X-ray diffraction pattern of columnar crystals of L-cystine obtained in Example 1.

【図2】実施例6で得られたL−シスチンの針状晶の粉
末X線回折図である。
FIG. 2 is a powder X-ray diffraction pattern of needle crystals of L-cystine obtained in Example 6.

Claims (7)

【特許請求の範囲】[Claims] 【請求項1】遷移金属イオンおよびメタリン酸を含有す
るL−シスチン溶液からL−シスチンを晶析することを
特徴とする、L−シスチンの柱状結晶の製造方法。
1. A method for producing columnar crystals of L-cystine, which comprises crystallizing L-cystine from an L-cystine solution containing a transition metal ion and metaphosphoric acid.
【請求項2】メタリン酸がヘキサメタリン酸であること
を特徴とする請求項1に記載の方法。
2. The method according to claim 1, wherein the metaphosphoric acid is hexametaphosphoric acid.
【請求項3】遷移金属イオンが第一鉄イオンまたは第二
鉄イオンであることを特徴とする請求項1または請求項
2に記載の方法。
3. The method according to claim 1 or 2, wherein the transition metal ion is a ferrous ion or a ferric ion.
【請求項4】Cu−Kα線を用いて、粉末X線回折法で
測定した場合に、約15.0度、16.8度、21.5
度、23.7度、24.2、及び28.8度の回折角度
(2θ)にピ−クを有する回折図形が得られることを特
徴とするL−シスチンの結晶。
4. When measured by powder X-ray diffractometry using Cu-Kα ray, it is about 15.0 degrees, 16.8 degrees, 21.5 degrees.
A crystal of L-cystine, characterized in that diffraction patterns having peaks at diffraction angles (2θ) of degrees, 23.7 degrees, 24.2, and 28.8 degrees are obtained.
【請求項5】メタリン酸を含有するL−シスチン溶液か
ら晶析することを特徴とする、請求項4に記載のL−シ
スチン結晶を製造する方法。
5. The method for producing L-cystine crystals according to claim 4, which comprises crystallization from an L-cystine solution containing metaphosphoric acid.
【請求項6】メタリン酸がヘキサメタリン酸であること
を特徴とする請求項5に記載の方法。
6. The method according to claim 5, wherein the metaphosphoric acid is hexametaphosphoric acid.
【請求項7】コバルトイオンまたはニッケルイオンの存
在下、L−シスチンを晶析することを特徴とする請求項
5または請求項6に記載の方法。
7. The method according to claim 5, wherein L-cystine is crystallized in the presence of cobalt ion or nickel ion.
JP15750494A 1994-07-08 1994-07-08 Crystallization method of L-cystine and novel crystal Expired - Fee Related JP3541440B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP15750494A JP3541440B2 (en) 1994-07-08 1994-07-08 Crystallization method of L-cystine and novel crystal

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15750494A JP3541440B2 (en) 1994-07-08 1994-07-08 Crystallization method of L-cystine and novel crystal

Publications (2)

Publication Number Publication Date
JPH0827101A true JPH0827101A (en) 1996-01-30
JP3541440B2 JP3541440B2 (en) 2004-07-14

Family

ID=15651134

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15750494A Expired - Fee Related JP3541440B2 (en) 1994-07-08 1994-07-08 Crystallization method of L-cystine and novel crystal

Country Status (1)

Country Link
JP (1) JP3541440B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015164911A (en) * 2014-02-05 2015-09-17 東ソー株式会社 Styrenesulfonic acid lithium

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015164911A (en) * 2014-02-05 2015-09-17 東ソー株式会社 Styrenesulfonic acid lithium

Also Published As

Publication number Publication date
JP3541440B2 (en) 2004-07-14

Similar Documents

Publication Publication Date Title
US5296639A (en) Adipic acid purification
RU2235065C2 (en) Method for producing potassium sulfate from potash and sodium sulfate
JP3694921B2 (en) Purification method of valine
JPH10237030A (en) Purification of branched chain amino acid
JPH0827101A (en) Crystallization of l-cystine and new crystals
JPH0225900B2 (en)
EP3856732A1 (en) Process and salts for the preparation of 2,5-furandicarboxylic acid
JPH04352796A (en) Crystallization of aspartame
JPH08291135A (en) Production of taurine analog
JPH092999A (en) Production of aluminum lactate crystal
JP4635314B2 (en) Method for producing sodium sulfate
SU806606A1 (en) Method of potassium sulfate production
RU2285667C1 (en) Method of production of the high purity magnesium nitrate hexahydrate from the technical solution of magnesium nitrate
JP3855281B2 (en) Aspartic acid crystallization method
EP0279542B1 (en) Novel aspartic acid crystals and a process for the production thereof
JPH10316646A (en) Production of high-purity crystalline o-methyliso urea acetate and crystalline o-methylisourea acetate obtained by the same
RU2246480C1 (en) Method for preparing copper (ii) acetate monohydrate
JPS604168A (en) Crystallization of tryptophan
JPH01190661A (en) Purification of 4,4'-dihydroxydiphenylsulfone
JPS5859964A (en) Novel type crystal of l-cystine
JPH0153867B2 (en)
JPS6258345B2 (en)
JP2001181254A (en) Method for purifying creatine
JP2024001848A (en) Cyclic preparation method for columnar taurine
JPH027584B2 (en)

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20040212

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20040309

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20040322

R150 Certificate of patent (=grant) or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100409

Year of fee payment: 6

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100409

Year of fee payment: 6

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110409

Year of fee payment: 7

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110409

Year of fee payment: 7

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120409

Year of fee payment: 8

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120409

Year of fee payment: 8

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130409

Year of fee payment: 9

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130409

Year of fee payment: 9

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140409

Year of fee payment: 10

LAPS Cancellation because of no payment of annual fees